RSAD2, as an antiviral protein, could restrict the amplification of DNA or RNA viruses by blocking the positive-sense RNA amplification during the early stages of the virus infection, targeting viral nonstructural proteins to promote its proteasomes degradation, or disrupting the lipid rafts [33,34,35]. This evidence concerns the gene RSAD2 and viral infectious disease.